MegaRobo Co. Ltd. has raised $200 million in new funding, the China-based robotics and biotech company announced, money it will put toward its core technology and toward expanding automated life-sciences infrastructure built for increasingly complex physical systems. The company, founded in 2016, makes robotic systems that allow artificial intelligence software to carry out physical experiments, and it also sells precision measurement and inspection tools to manufacturers.
The round drew participation from Oman Investment Authority, Asia Investment Capital, Granite Asia, Sinovation Ventures and CMB International. MegaRobo has now raised $600 million across multiple rounds, including close to $300 million in Series C financing during 2022.
Founder and Chief Executive Daniel Huang described a transition in how AI systems acquire knowledge. Earlier generations, he said, learned from knowledge humanity had already accumulated, while future systems will increasingly learn by acting in the physical world through experiments, production and ongoing feedback. That change, in his account, moves AI from software that interprets the world to software that can help generate new knowledge, materials, processes and products.
MegaRobo's most heavily promoted products are Megalaxy Lab, an AI-connected experimental platform, and CellVue T2000, an automated cell-imaging instrument, both of which appear on the company's English-language homepage. The company also sells more specialized laboratory equipment, including the Auflo sample-preparation workstation and the Seloris cell culturing automation system. Megalaxy Lab serves as the public face of MegaRobo's AI-for-science strategy, while CellVue and the other systems are concrete examples of the instruments the company builds for the industry.
Through Megalaxy, the company says it is making real-world experimentation programmable and accessible. Researchers and AI agents can configure experiments, route them through automated laboratory systems, track execution, receive structured, machine-readable results and feed those results into the next cycle of scientific reasoning, according to MegaRobo. The company said this includes virtual large data readouts that can be amplified as digital twins representing scientific data, protein design, biochemistry and other properties.
MegaRobo said it is working with industry partners including Tencent Cloud and Twist Bioscience to broaden its reach in the AI science community, including through the launch of Poreva Open, a global AI protein design challenge open to all models and technical approaches. Megalaxy will supply wet-lab validation for more than 10,000 protein design sequences, giving participants a way to test models against real experimental data.
The company is also developing the One Intelligence Stack as a shared technology foundation for instruments, machines, materials processes and real-world feedback. MegaRobo describes it not as a set of isolated AI applications and products but as chain infrastructure that lets AI act, learn and observe across complex physical environments.
More company and startup news from TechManNews.





